Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
UK national study of barriers to renal transplantation in children.
Kim JS, Marlais M, Balasubramanian R, Muorah M, Inward C, Smith GC, Reynolds BC, Yadav P, Morgan H, Shenoy M, Tse Y, Hussain F, Grylls S, Kessaris N, Sinha MD, Marks SD; British Association for Paediatric Nephrology. Kim JS, et al. Among authors: muorah m. Arch Dis Child. 2021 Apr;106(4):384-386. doi: 10.1136/archdischild-2019-318272. Epub 2020 Apr 2. Arch Dis Child. 2021. PMID: 32241783
Advanced chronic kidney disease among UK children.
Plumb L, Magadi W, Casula A, Reynolds BC, Convery M, Haq S, Hegde S, Lunn A, Malina M, Morgan H, Muorah M, Tyerman K, Sinha MD, Wallace D, Inward C, Marks S, Nitsch D, Medcalf J. Plumb L, et al. Among authors: muorah m. Arch Dis Child. 2022 Oct 19;107(11):1043-1045. doi: 10.1136/archdischild-2021-323686. Arch Dis Child. 2022. PMID: 35732469
A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO).
Hayes WN, Laing E, Brown R, Silsby L, Smith L, Thomas H, Kaloyirou F, Sharma R, Griffiths J, Hume-Smith H, Marks SD, Kessaris N, Christian M, Dudley J, Shenoy M, Malina M, Muorah M, Ware N, Yadav P, Reynolds B, Bryant W, Spiridou A, Wray J, Peters MJ. Hayes WN, et al. Among authors: muorah m. Kidney Int. 2024 Feb;105(2):364-375. doi: 10.1016/j.kint.2023.09.032. Epub 2023 Oct 31. Kidney Int. 2024. PMID: 37914088 Free PMC article. Clinical Trial.
Joining the dots: Answers.
Bose N, Chaudhuri K, Muorah M, Sinha R. Bose N, et al. Among authors: muorah m. Pediatr Nephrol. 2022 Jul;37(7):1525-1528. doi: 10.1007/s00467-021-05415-y. Epub 2022 Jan 27. Pediatr Nephrol. 2022. PMID: 35084566 No abstract available.
Joining the dots: Questions.
Bose N, Chaudhuri K, Muorah M, Sinha R. Bose N, et al. Among authors: muorah m. Pediatr Nephrol. 2022 Jul;37(7):1523-1524. doi: 10.1007/s00467-021-05394-0. Epub 2022 Jan 27. Pediatr Nephrol. 2022. PMID: 35084567 No abstract available.
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial.
Frishberg Y, Deschênes G, Groothoff JW, Hulton SA, Magen D, Harambat J, Van't Hoff WG, Lorch U, Milliner DS, Lieske JC, Haslett P, Garg PP, Vaishnaw AK, Talamudupula S, Lu J, Habtemariam BA, Erbe DV, McGregor TL, Cochat P; study collaborators. Frishberg Y, et al. Clin J Am Soc Nephrol. 2021 Jul;16(7):1025-1036. doi: 10.2215/CJN.14730920. Epub 2021 May 13. Clin J Am Soc Nephrol. 2021. PMID: 33985991 Free PMC article. Clinical Trial.
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O'Riordan WD, Cochat P, Deschênes G, Shasha-Lavsky H, Saland JM, Van't Hoff WG, Fuster DG, Magen D, Moochhala SH, Schalk G, Simkova E, Groothoff JW, Sas DJ, Meliambro KA, Lu J, Sweetser MT, Garg PP, Vaishnaw AK, Gansner JM, McGregor TL, Lieske JC; ILLUMINATE-A Collaborators. Garrelfs SF, et al. N Engl J Med. 2021 Apr 1;384(13):1216-1226. doi: 10.1056/NEJMoa2021712. N Engl J Med. 2021. PMID: 33789010 Clinical Trial.
19 results